Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 15724149)

1.

Leptin regulation of bone resorption by the sympathetic nervous system and CART.

Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G.

Nature. 2005 Mar 24;434(7032):514-20. Epub 2005 Feb 20.

PMID:
15724149
2.

Physiology: do neural signals remodel bone?

Elmquist JK, Strewler GJ.

Nature. 2005 Mar 24;434(7032):447-8. No abstract available.

PMID:
15791237
3.

Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast.

Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ.

J Biol Chem. 2005 Apr 29;280(17):17497-506. Epub 2005 Feb 24.

4.

Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual.

Kajimura D, Hinoi E, Ferron M, Kode A, Riley KJ, Zhou B, Guo XE, Karsenty G.

J Exp Med. 2011 Apr 11;208(4):841-51. doi: 10.1084/jem.20102608. Epub 2011 Mar 28.

5.

The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function.

Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE.

J Biol Chem. 2000 Aug 18;275(33):25163-72.

6.

Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.

Fonseca TL, Jorgetti V, Costa CC, Capelo LP, Covarrubias AE, Moulatlet AC, Teixeira MB, Hesse E, Morethson P, Beber EH, Freitas FR, Wang CC, Nonaka KO, Oliveira R, Casarini DE, Zorn TM, Brum PC, Gouveia CH.

J Bone Miner Res. 2011 Mar;26(3):591-603. doi: 10.1002/jbmr.243.

PMID:
20814988
7.

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.

Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG.

J Cell Sci. 2006 Apr 1;119(Pt 7):1283-96. Epub 2006 Mar 7.

8.

High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.

Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P.

Mol Cell Biol. 2002 Sep;22(17):6222-33.

9.
10.

Regulatory mechanisms of osteoblast and osteoclast differentiation.

Katagiri T, Takahashi N.

Oral Dis. 2002 May;8(3):147-59. Review.

PMID:
12108759
11.

Leptin regulates bone formation via the sympathetic nervous system.

Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G.

Cell. 2002 Nov 1;111(3):305-17.

PMID:
12419242
12.

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.

Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL.

J Biol Chem. 2003 Dec 12;278(50):50259-72. Epub 2003 Oct 1.

13.

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.

Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.

J Bone Miner Res. 2004 Nov;19(11):1873-81. Epub 2004 Aug 16.

PMID:
15476588
14.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
15.

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T.

J Biol Chem. 2003 Jun 27;278(26):23971-7. Epub 2003 Apr 15.

18.

EBF2 regulates osteoblast-dependent differentiation of osteoclasts.

Kieslinger M, Folberth S, Dobreva G, Dorn T, Croci L, Erben R, Consalez GG, Grosschedl R.

Dev Cell. 2005 Dec;9(6):757-67.

19.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

PMID:
16059637
20.

Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.

Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM.

J Bone Miner Res. 2005 Oct;20(10):1851-7. Epub 2005 May 31.

PMID:
16160743
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk